Literature DB >> 24641965

Relation of preprocedural assessment of myocardial contractility reserve on outcomes of aortic stenosis patients with impaired left ventricular function undergoing transcatheter aortic valve implantation.

Israel M Barbash1, Sa'ar Minha1, Itsik Ben-Dor1, Danny Dvir1, Marco A Magalhaes1, Rebecca Torguson1, Petros Okubagzi1, Lowell F Satler1, Augusto D Pichard1, Ron Waksman2.   

Abstract

Transcatheter aortic valve implantation (TAVI) is associated with improved left ventricular (LV) function in patients with aortic stenosis (AS) and LV dysfunction; however, the outcome after TAVI of patients with low left ventricular ejection fraction (LVEF) is unclear. This study aimed to characterize the baseline, procedural, and long-term outcomes of patients with low LVEF undergoing TAVI and to assess the prognostic utility of pre-TAVI balloon aortic valvuloplasty (BAV) and dobutamine stress echocardiography (DSE) to predict TAVI benefits. Consecutive patients with symptomatic severe AS who underwent TAVI from 2007 to 2013 were analyzed. Two groups were compared: normal or near normal LV function (LVEF >45%) and LVEF ≤45% at baseline. In total, 371 patients were analyzed; 272 (73%) had preserved LVEF and 99 (27%) had low LVEF. Patients with low LVEF had higher Society of Thoracic Surgeons score and EuroSCORE. Short- and long-term mortality was similar between groups (1-year rate: 22.2% vs 22.4%, p = 0.79). Of the patients with low LVEF, 24% demonstrated improvement (≥10%) in LVEF at 30 days; patients with improvement had lower mortality at 1 year than those without (8% vs 27%, p = 0.06). Contractile reserve in DSE did not predict LVEF recovery in patients with low LVEF but did predict lower mortality. LVEF recovery after BAV predicted greater LVEF improvement after TAVI. In conclusion, patients with severe AS and impaired LV function benefit from TAVI and have comparable procedural outcomes compared with patients with preserved LVEF. Both DSE and BAV provide complementary data with regard to recovery of LVEF and mortality, both periprocedural and late after TAVI.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24641965     DOI: 10.1016/j.amjcard.2014.01.433

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Challenges in Aortic Valve Stenosis: Low-Flow States Diagnosis, Management, and a Review of the Current Literature.

Authors:  Matthew W Sherwood; Todd L Kiefer
Journal:  Curr Cardiol Rep       Date:  2017-10-30       Impact factor: 2.931

2.  Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry.

Authors:  Frédéric Maes; Stamatios Lerakis; Henrique Barbosa Ribeiro; Martine Gilard; João L Cavalcante; Raj Makkar; Howard C Herrmann; Stephan Windecker; Maurice Enriquez-Sarano; Asim N Cheema; Luis Nombela-Franco; Ignacio Amat-Santos; Antonio J Muñoz-García; Bruno Garcia Del Blanco; Alan Zajarias; John C Lisko; Salim Hayek; Vasilis Babaliaros; Florent Le Ven; Thomas G Gleason; Tarun Chakravarty; Wilson Szeto; Marie-Annick Clavel; Alberto de Agustin; Vicenç Serra; John T Schindler; Abdellaziz Dahou; Mohammed Salah-Annabi; Emilie Pelletier-Beaumont; Melanie Côté; Rishi Puri; Philippe Pibarot; Josep Rodés-Cabau
Journal:  JAMA Cardiol       Date:  2019-01-01       Impact factor: 14.676

3.  Modern Use of Echocardiography in Transcatheter Aortic Valve Replacement: an Up-Date.

Authors:  Cristina Caldararu; Serban Balanescu
Journal:  Maedica (Bucur)       Date:  2016-12

Review 4.  Efficacy of transcatheter aortic valve implantation in patients with aortic stenosis and reduced LVEF. A systematic review.

Authors:  X Luo; Z Zhao; H Chai; C Zhang; Y Liao; Q Li; Y Peng; W Liu; X Ren; Q Meng; C Chen; M Chen; Y Feng; D Huang
Journal:  Herz       Date:  2015-02-26       Impact factor: 1.443

5.  Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.

Authors:  Suzanne J Baron; Suzanne V Arnold; Howard C Herrmann; David R Holmes; Wilson Y Szeto; Keith B Allen; Adnan K Chhatriwalla; Sreekaanth Vemulapali; Sean O'Brien; Dadi Dai; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2016-05-24       Impact factor: 24.094

6.  Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.

Authors:  Edward T Carreras; Tsuyoshi Kaneko; Fernando Ramirez-Del Val; Marc P Pelletier; Piotr S Sobieszczyk; Deepak L Bhatt; Pinak B Shah
Journal:  Catheter Cardiovasc Interv       Date:  2017-10-08       Impact factor: 2.692

7.  Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: a new paradigm for the heart team decision making.

Authors:  Francesco Saia; Carolina Moretti; Gianni Dall'Ara; Cristina Ciuca; Nevio Taglieri; Alessandra Berardini; Pamela Gallo; Marina Cannizzo; Matteo Chiarabelli; Niccolò Ramponi; Linda Taffani; Maria Letizia Bacchi-Reggiani; Cinzia Marrozzini; Claudio Rapezzi; Antonio Marzocchi
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

8.  Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation: a narrative review.

Authors:  Thomas R Keeble; Arif Khokhar; Mohammed Majid Akhtar; Anthony Mathur; Roshan Weerackody; Simon Kennon
Journal:  Open Heart       Date:  2016-12-07

9.  Contemporary Outcomes in Low-Gradient Aortic Stenosis Patients Who Underwent Dobutamine Stress Echocardiography.

Authors:  Kimi Sato; Kesavan Sankaramangalam; Krishna Kandregula; Jennifer A Bullen; Samir R Kapadia; Amar Krishnaswamy; Stephanie Mick; L Leonardo Rodriguez; Richard A Grimm; Venu Menon; Milind Y Desai; Lars G Svensson; Brian P Griffin; Zoran B Popović
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.